Multiplex-inhibitor bead mass spectrometry reveals differential kinome signatures in newly diagnosed and recurrent glioblastoma
A. D. Jermakowicz, A. M. Kurimchak, J. Sarkaria, R. Komotar, M. E. Ivan, S. Schürer, J. S. Duncan, N. Ayad
This study uses MIB-MS to compare kinase profiles between newly diagnosed and recurrent glioblastoma, identifying differences in signaling pathways associated with tumor recurrence.
bioRxiv · Sep 21, 2020 · PreprintCancer Biology